Group 1 - The company Chengdu Yuandong Pharmaceutical Co., Ltd. has been awarded the China Patent Excellence Award for its invention patent "A Fumaric Acid Bisoprolol I Crystal Form and Its Preparation Method" related to Fumaric Acid Bisoprolol Tablets (Su Nuo Le) [1][2] - The China Patent Award is co-hosted by the National Intellectual Property Administration and the World Intellectual Property Organization, and it is the only government award in China specifically for granting patent rights for inventions [1] - In the 25th China Patent Award, a total of 607 China Patent Excellence Awards were granted, along with other categories such as gold and silver awards for patents and designs [1] Group 2 - The award signifies recognition of the company's efforts in innovative drug research and intellectual property protection, highlighting the technological advancement, innovation, and clinical value of the drug [3] - As of December 31, 2024, the company has applied for a total of 425 patents, including 408 invention patents, with 156 patents authorized, including 142 invention patents [3] - The company aims to continue focusing on innovation and intellectual property management to develop more high-quality innovative drugs, contributing to the health of the Chinese population and benefiting global patients [3]
成都苑东生物制药股份有限公司关于自愿披露获得第二十五届中国专利优秀奖的公告